B-PLL
Showing 1 - 25 of >10,000
CLL, SLL, HCL Trial in Dresden
Recruiting
- CLL
- +7 more
-
Dresden, Sachsen, GermanyBAG Freiberg-Richter, Jacobasch, Wolf, Illmer
Apr 29, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- acalabrutinib
- +3 more
-
Columbus, OhioResearch Site
Mar 11, 2022
Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial
Active, not recruiting
- Contiguous Stage II Small Lymphocytic Lymphoma
- +11 more
- MOR00208
- +2 more
-
Columbus, OhioThe Ohio State University Comprehensive Cancer Center
Feb 24, 2022
Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)
Completed
- Leukemia
- +2 more
-
Boston, Massachusetts
- +14 more
Nov 23, 2022
Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)
Recruiting
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
-
Najing, Jiangsu, ChinaJiangsu Provincial People's Hospital
Sep 26, 2022
Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +15 more
- Anti-CD19/CD20/CD22 CAR T-Cells
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 4, 2022
Crohn's Disease Trial in United States (CDPATH™, Blood Draw)
Recruiting
- Crohn's Disease
- CDPATH™
- Blood Draw
-
Phoenix, Arizona
- +54 more
Nov 10, 2022
T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)
Completed
- T-cell-prolymphocytic Leukemia
- Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
- Alemtuzumab
-
Cologne, GermanyUniversity Hospital Cologne
Dec 16, 2021
Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt
Active, not recruiting
- Prolymphocytic Leukemia
- +4 more
- Selinexor
- +3 more
-
Columbus, Ohio
- +1 more
Apr 29, 2022
T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)
Not yet recruiting
- T-Cell Non-Hodgkin Lymphoma
- +14 more
- WU-CART-007
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Microvascular Reactivity in Peripheral Artery Disease
Not yet recruiting
- Peripheral Artery Disease
- No Intervention-Clinical Assessments only
- (no location specified)
Sep 21, 2021
Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)
Recruiting
- Pertussis/Whooping Cough
- Bordetella pertussis B1917
- Azithromycin Pill
-
Southampton, Hampshire, United KingdomNIHR Clinical Research Facility
Apr 26, 2023
Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene
Recruiting
- Hepatitis B, Chronic
- genotyping
-
Sohag, EgyptSohag university Hospital
Sep 4, 2023
Total Knee Replacement, Knee Arthroplasty Trial in New Haven (Bupivacaine-Liposomal Bupivacaine, Bupivacaine -Dexamethasone
Recruiting
- Total Knee Replacement
- Knee Arthroplasty
- Bupivacaine-Liposomal Bupivacaine
- Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate
-
New Haven, Connecticut
- +1 more
Feb 17, 2023
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)
Completed
- COVID-19
- Influenza
- Lucira COVID-19 & Flu Test
-
Cullman, Alabama
- +6 more
Nov 16, 2023
Tenofovir Disoproxil Fumarate and Entcavir in Treatment of
Recruiting
- Chronic Hepatitis b Patients
- Tenofovir Disoproxil Fumarate and Entcavir
-
Sohag, EgyptSohag University hospitals
May 22, 2023
Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)
Recruiting
- Drug-Induced Nephropathy
- N Acetylcysteine
-
Cairo, EgyptHelwan University
Nov 7, 2023
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
JAK-i on RA B-lymphocytes Tolerance and Disease Resolution
Recruiting
- Rheumatoid Arthritis
- B lymphocyte profiling
-
Rome, ItalyDivision of Clinical Immunology, Fondazione Policlinico Universi
Feb 22, 2023
B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- HY004
- +2 more
- (no location specified)
Aug 18, 2023
SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),
Active, not recruiting
- SARS-CoV2 Infection
- +3 more
- BNT162b2
- +5 more
-
Long Beach, California
- +34 more
Jan 10, 2023